CD8A and cancer: The featured clusters of the cured groups showed higher expression of type 2 interferon response, checkpoint inhibition, and CD8+ T cell activation genes, which is beneficial for killing cancer cells (Figure 4g–k; Figures S13 and S14, Supporting Information).